BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 24086627)

  • 1. Are they really lost? "true" status and reasons for treatment discontinuation among HIV infected patients on antiretroviral therapy considered lost to follow up in Urban Malawi.
    Tweya H; Feldacker C; Estill J; Jahn A; Ng'ambi W; Ben-Smith A; Keiser O; Bokosi M; Egger M; Speight C; Gumulira J; Phiri S
    PLoS One; 2013; 8(9):e75761. PubMed ID: 24086627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding factors, outcomes and reasons for loss to follow-up among women in Option B+ PMTCT programme in Lilongwe, Malawi.
    Tweya H; Gugsa S; Hosseinipour M; Speight C; Ng'ambi W; Bokosi M; Chikonda J; Chauma A; Khomani P; Phoso M; Mtande T; Phiri S
    Trop Med Int Health; 2014 Nov; 19(11):1360-6. PubMed ID: 25087778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss to follow-up before and after initiation of antiretroviral therapy in HIV facilities in Lilongwe, Malawi.
    Tweya H; Oboho IK; Gugsa ST; Phiri S; Rambiki E; Banda R; Mwafilaso J; Munthali C; Gupta S; Bateganya M; Maida A
    PLoS One; 2018; 13(1):e0188488. PubMed ID: 29373574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tracing of patients lost to follow-up and HIV transmission: mathematical modeling study based on 2 large ART programs in Malawi.
    Estill J; Tweya H; Egger M; Wandeler G; Feldacker C; Johnson LF; Blaser N; Vizcaya LS; Phiri S; Keiser O
    J Acquir Immune Defic Syndr; 2014 Apr; 65(5):e179-86. PubMed ID: 24326599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A retrospective notes-based review of patients lost to follow-up from anti-retroviral therapy at Mulanje Mission Hospital, Malawi.
    Webb S; Hartland J
    Malawi Med J; 2018 Jun; 30(2):73-78. PubMed ID: 30627332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Status of HIV-infected patients classified as lost to follow up from a large antiretroviral program in southwest Nigeria.
    Balogun M; Meloni ST; Igwilo UU; Roberts A; Okafor I; Sekoni A; Ogunsola F; Kanki PJ; Akanmu S
    PLoS One; 2019; 14(7):e0219903. PubMed ID: 31344057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes and associated risk factors of patients traced after being lost to follow-up from antiretroviral treatment in Lilongwe, Malawi.
    Weigel R; Hochgesang M; Brinkhof MW; Hosseinipour MC; Boxshall M; Mhango E; Nkwazi B; Tweya H; Kamlaka M; Chagwera F; Phiri S
    BMC Infect Dis; 2011 Jan; 11():31. PubMed ID: 21272350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tracing People Living With Human Immunodeficiency Virus Who Are Lost to Follow-up at Antiretroviral Therapy Programs in Southern Africa: A Sampling-Based Cohort Study in 6 Countries.
    Ballif M; Christ B; Anderegg N; Chammartin F; Muhairwe J; Jefferys L; Hector J; van Dijk J; Vinikoor MJ; van Lettow M; Chimbetete C; Phiri SJ; Onoya D; Fox MP; Egger M
    Clin Infect Dis; 2022 Jan; 74(2):171-179. PubMed ID: 33993219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation and Operational Research: Early Tracing of Children Lost to Follow-Up From Antiretroviral Treatment: True Outcomes and Future Risks.
    Ardura-Garcia C; Feldacker C; Tweya H; Chaweza T; Kalulu M; Phiri S; Wang D; Weigel R
    J Acquir Immune Defic Syndr; 2015 Dec; 70(5):e160-7. PubMed ID: 26218409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda.
    Kiwanuka J; Mukulu Waila J; Muhindo Kahungu M; Kitonsa J; Kiwanuka N
    PLoS One; 2020; 15(4):e0217606. PubMed ID: 32255796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Male, mobile, and moneyed: loss to follow-up vs. transfer of care in an urban African antiretroviral treatment clinic.
    Marson KG; Tapia K; Kohler P; McGrath CJ; John-Stewart GC; Richardson BA; Njoroge JW; Kiarie JN; Sakr SR; Chung MH
    PLoS One; 2013; 8(10):e78900. PubMed ID: 24205345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
    Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
    PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-transfers and factors associated with successful tracing among persons lost to follow-up from HIV care, Sheema District, Southwestern Uganda: retrospective medical records review, 2017-2021.
    Ssemwogerere A; Kamya JK; Nuwasasira L; Ahura C; Isooba DI; Wakida EK; Obua C; Migisha R
    AIDS Res Ther; 2022 Sep; 19(1):44. PubMed ID: 36127692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of loss to follow-up among children on long-term antiretroviral therapy in Zambia (2003-2015).
    Mutanga JN; Mutembo S; Ezeamama AE; Song X; Fubisha RC; Mutesu-Kapembwa K; Sialondwe D; Simuchembu B; Chinyonga J; Thuma PE; Whalen CC
    BMC Public Health; 2019 Aug; 19(1):1120. PubMed ID: 31416432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Who will be lost? Identifying patients at risk of loss to follow-up in Malawi. The DREAM Program Experience.
    Mancinelli S; Nielsen-Saines K; Germano P; Guidotti G; Buonomo E; Scarcella P; Lunghi R; Sangare H; Orlando S; Liotta G; Marazzi MC; Palombi L
    HIV Med; 2017 Sep; 18(8):573-579. PubMed ID: 28150466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity of reported retention in antiretroviral therapy after roll-out to peripheral facilities in Mozambique: Results of a retrospective national cohort analysis.
    Lafort Y; Couto A; Sunderbrink U; Hoek R; Shargie E; Zhao J; Viisainen K; Simwaka B
    PLoS One; 2018; 13(6):e0198916. PubMed ID: 29927961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retention in care among HIV-positive patients initiating second-line antiretroviral therapy: a retrospective study from an Ethiopian public hospital clinic.
    Wilhelmson S; Reepalu A; Balcha TT; Jarso G; Björkman P
    Glob Health Action; 2016; 9():29943. PubMed ID: 26765104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retention in HIV/AIDS Management Services: is it Really Poor? The Case of Yaounde Central Hospital in Cameroon.
    Kouanfack C; Bede F; Nkfusai CN; Wepngong E; Venyuy MA; Hubert C; Sam DM; Cumber SN
    Int J MCH AIDS; 2020; 9(2):207-212. PubMed ID: 32704407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retention and viral suppression in a cohort of HIV patients on antiretroviral therapy in Zambia: Regionally representative estimates using a multistage-sampling-based approach.
    Sikazwe I; Eshun-Wilson I; Sikombe K; Czaicki N; Somwe P; Mody A; Simbeza S; Glidden DV; Chizema E; Mulenga LB; Padian N; Duncombe CJ; Bolton-Moore C; Beres LK; Holmes CB; Geng E
    PLoS Med; 2019 May; 16(5):e1002811. PubMed ID: 31150380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Treatment Retention Rate in HIV-Infected Patients Receiving Antiretroviral Therapy at Two Large HIV Clinics in Hanoi, Vietnam.
    Matsumoto S; Tanuma J; Mizushima D; Nguyen NC; Pham TT; Do CD; Nguyen TQ; Nguyen DT; Nguyen HD; Nguyen LT; Nguyen KV; Oka S
    PLoS One; 2015; 10(9):e0139594. PubMed ID: 26422474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.